aesculap chifa sp. z o.o.

What aesculap chifa sp. z o.o. does

Aesculap Chifa sp. z o.o. is the Polish operating subsidiary of B. Braun Melsungen AG, a German family-owned medical technology conglomerate founded in 1839. Headquartered at ul. Tysiąclecia 14, Nowy Tomyśl, Poland, the company manufactures and distributes surgical instruments, sterile container systems, infusion therapy devices, dialysis equipment, and a broad portfolio of medical technology products across 19 therapy areas including spine surgery, minimally invasive surgery, robotic surgery, interventional vascular therapy, neurosurgery, orthopedics, oncology, wound care, stoma care, infection prevention, pain therapy, nutritional therapy, urology, dental, and veterinary medicine.

The company's core product pillars are the Space plus Infusion System — an advanced digitized infusion pump platform with smart pump technology and digital medication management — and the Nexadia Mobile Companion, a mobile-enabled nephrology care platform providing patient data access for dialysis documentation and shunt monitoring. Aesculap-branded surgical instruments and sterile container systems anchor the surgical portfolio, complemented by the ATS technical service offering warranty and post-warranty repair. The technology stack includes proprietary infusion systems, sterile supply management, and mobile companion applications, with third-party integrations spanning Salesforce Marketing Cloud, Adobe Analytics, LinkedIn Sales Navigator, and the My B. Braun customer extranet portal.

Revenue is generated through B2B enterprise sales to hospitals, clinics, and healthcare providers via a direct field sales force of medical representatives, supplemented by the My B. Braun digital portal and multi-year contract-based pricing. The business model combines hardware sales (medical devices, surgical instruments, custom surgical procedure sets) with professional services revenue (technical service and maintenance). As part of the B. Braun Group, which reported €9.4 billion in 2025 revenues with 5.1% comparable growth, Aesculap Chifa operates without standalone public financial disclosure. Its primary customer segments are hospitals and healthcare providers across all major therapy areas, with a secondary segment of healthcare professionals (surgeons, physicians, nurses) requiring medical devices and therapeutic solutions.

Name

aesculap chifa sp. z o.o.

Legal name

Aesculap Chifa Sp. z o. o.

Website

https://chifa.com.pl

Company type

Private

Founded year

1839

Operating status

Operating

Short description

Aesculap Chifa sp. z o.o. is the Polish operating subsidiary of B. Braun Melsungen AG, manufacturing and distributing surgical instruments, sterile container systems, infusion pumps, dialysis equipment, and medical technology products across 19 therapy areas to hospitals, clinics, and healthcare providers in Poland.

Ownership category

akta.pro rank

Product category

Medical Devices and Surgical Instruments

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113), Medical Equipment and Supplies Manufacturing (3391)

SIC

Surgical & Medical Instruments & Apparatus (3841), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Surgical & Procedural Instruments (Scalpels, Forceps, Retractors) (HLAMAFAA)

akta.pro secondary industries

Medical & Healthcare Hygiene Disposables (Patient Wipes, Underpads) (IMAMAGAF), Sterilization Services & Contract Reprocessing (ETO/Gamma/E-beam providers) (HLAHANAB)

Keywords

• Medical devices
• Surgical instruments
• Infusion therapy systems
• Sterile container systems
• Healthcare technology

Headquarters

HQ city

Nowy Tomyśl

HQ country

Poland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Medical Technology Products: Sale of medical devices, surgical instruments, infusion systems, and healthcare equipment to hospitals, clinics, and healthcare providers through direct enterprise sales and B2B partnerships.
2. Technical Services: Technical service and maintenance for medical instruments and devices including warranty and post-warranty support.
3. Customized Procedure Trays: Individual surgical procedure trays and sets tailored to customer specifications.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Aesculap Chifa sp. z o.o. is the Polish operating entity of B. Braun Melsungen AG, selling and distributing medical technology products and surgical instruments to healthcare providers in Poland. Its portfolio covers surgical instruments, infusion therapy systems (including the digitized Space plus pump), sterile container systems, renal replacement therapy products, wound care, orthopedic implants, and custom surgical procedure sets. The company also provides technical inspection and repair services (ATS) for medical instruments under warranty and post-warranty.

Product overview

B. Braun is a global medical technology company operating in Poland through Aesculap Chifa sp. z o.o. The portfolio consists of a unified product ecosystem organized around core platforms and therapy areas. Key product pillars include the Space® plus digital infusion system (advanced digitized medication management with smart pump technology), the Nexadia Mobile Companion (mobile nephrology care platform), and Aesculap-branded surgical instruments and container systems. The company provides 19 distinct therapy areas spanning surgical specialties (spine, minimally invasive, robotic, vascular, neurosurgery, orthopedics), chronic disease management (oncology, renal replacement, pain therapy), and supportive care (wound care, stoma, infection prevention, nutritional therapy). Solutions layer includes B2B partnership programs, custom surgical sets, discharge management, oncology medication management, smart infusion systems, and surgical resource management. The company also operates My B. Braun, a customer extranet portal providing digital access to product information, documentation, and direct communication with B. Braun representatives.

Differentiator

Problem solved

Functional benefit

Products and services

• Space plus Infusion System Advanced digitized infusion pump system for digital medication management with smart pump technology and healthcare professional connectivity, used by hospitals and infusion therapy departments.
• Nexadia Mobile Companion Mobile companion technology for nephrology patient care that makes patient data available on mobile devices, supporting dialysis documentation and shunt monitoring for renal care professionals.
• Aesculap Container Systems Sterile supply management and transport solutions for surgical instrument containers, setting standards in sterilization and operating room supply for hospitals and surgical departments.
• ATS Technical Service (Serwis Techniczny) Standalone technical inspection and repair service for medical instruments and devices, covering both warranty and post-warranty periods, for healthcare providers.
• Custom Surgical Sets (Indywidualne Zestawy Zabiegowe) Customized surgical procedure sets and trays tailored to specific clinical needs and customer specifications, used by hospitals and surgical departments.

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration15 records

Feature4 records

Partnerships

One partnership is on record.

• B. Braun Melsungen AG (Parent Group)coreStrategic or Co-development PartnerAesculap Chifa sp. z o.o. is a subsidiary of the B. Braun Group, operating as the Polish entity of the global medical technology company. The company benefits from Group resources, R&D, and global presence while maintaining local operations.

Scale indicators1 record

Recent moves5 records

Expansion highlights5 records

Direct peers

• Karl Storz SE & Co. KG: Family-owned German manufacturer of endoscopes and surgical instruments across multiple specialties. Directly comparable as a privately-held, European-rooted surgical instruments company with parallel Aesculap-style brand heritage and similar enterprise hospital sales motion.
• Intuitive Surgical, Inc. Global leader in robotic-assisted surgery with the da Vinci platform. Directly comparable as Aesculap Chifa has explicitly added Robotic Surgery to its therapy area, and both companies target the same hospital surgical departments and capital procurement budgets.
• CONMED Corporation: Mid-sized medtech focused on general surgery, orthopedic, and surgical instrument products. Comparable in scale and product mix to Aesculap Chifa's surgical instrument franchise, with similar hospital-channel go-to-market motion.

Broad incumbents

• Olympus Corporation (Medical Division): Global medtech incumbent with strong endoscopy and surgical instrument portfolio, plus broader therapeutic solutions. Overlaps directly with Aesculap Chifa's minimally invasive surgery and surgical instrument categories, and competes for the same hospital procurement budgets.
• Stryker Corporation: Large diversified medtech with significant surgical instruments, orthopedics, and endoscopy franchises. Direct overlap with Aesculap Chifa's surgical and orthopedic product lines, particularly in procedural and capital equipment categories.
• Johnson & Johnson MedTech (Ethicon): J&J's medtech arm includes Ethicon, the global leader in surgical sutures and specialty products. Directly comparable to Aesculap Chifa's Suture Materials and Specialty Products therapy area, as well as broader surgical instrument categories.
• Smith+Nephew: Global medical technology company with established positions in surgical instruments, wound care, and orthopedics. Overlaps directly with multiple Aesculap Chifa therapy areas including wound management and orthopedic surgical solutions.
• Medtronic plc: World's largest medtech by revenue, with parallel offerings in infusion therapy, vascular therapy, surgical instruments, and renal care. Direct competitor to Aesculap Chifa in smart infusion pumps and renal replacement therapy, with comparable global enterprise sales footprint.
• Becton, Dickinson and Company (BD): Major medical device manufacturer with extensive surgical instruments, infusion therapy, and urology/incontinence portfolios. Overlaps with several Aesculap Chifa therapy areas including infusion, urology & incontinence, and surgical consumables.

Emerging players

• Zimmer Biomet Holdings, Inc. Global orthopedic device leader with a strong reconstructive and surgical instrument portfolio. Overlaps with Aesculap Chifa's Orthopedics therapy area (hip, knee, spine) and shares the same large-joint and spine surgery customer base.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about aesculap chifa sp. z o.o.